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Coronary Artery Calcium Score, Distribution,
and Future Revascularization*
Todd C. Villines, MDBethesda, MarylandIn this issue of iJACC, Silverman et al. (1) report the
relationship of baseline Agatston coronary artery
calcium (CAC) score and coronary calcium distri-
bution with future incident coronary revascularization
in 6,540 MESA (Multi-Ethnic Study of Athero-
sclerosis) participants. The primary ﬁndings of
this novel analysis is that baseline calcium score
and the number of vessels with CAC were each
independently predictive of future coronary revas-
cularizations over a median follow-up of 8.5 years.See page 476Additionally, among subjects who underwent
revascularization, those with more diffuse baseline
CAC were at higher risk to undergo coronary artery
bypass graft (CABG) versus percutaneous coronary
intervention (PCI). Speciﬁcally, adjusted for overall
CAC score, individuals with 3- and 4-vessel CAC
were 3 to 4 times more likely to undergo coronary
revascularization than were patients with CAC in a
single vessel, and $3 vessel CAC was strongly
predictive of the risk for future CABG, particularly
when involving the left main coronary artery.
Conversely, the risk of CABG was low in the
absence of baseline diffuse coronary calciﬁcation (<3
vessels), and, not surprisingly, the absence of CAC*Editorials published in the JACC: Cardiovascular Imaging reﬂect the views
of the authors and do not necessarily represent the views of JACC: Cardio-
vascular Imaging or the American College of Cardiology.
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of this paper to disclose.was associated with extremely low rates of future
revascularizations.
At ﬁrst glance, the primary ﬁndings by the
authors appear to be axiomatic. CAC scoring is a
well-validated measure of the severity and distri-
bution of coronary atherosclerosis and is a powerful
predictor of future major adverse cardiovascular
eventsdevents often appropriately treated with
coronary revascularization, to include CABG in
cases of left main and/or multivessel coronary ar-
tery disease. The absence of CAC has been
consistently demonstrated to predict an excep-
tionally good prognosis and probably a low risk for
subsequent coronary revascularizations, particularly
in an asymptomatic screening cohort. With regard
to CAC distribution, a prior study of more than
25,000 asymptomatic subjects demonstrated that
those with left main or 3-vessel CAC had signif-
icantly higher rates of all-cause death as compared
with subjects with no disease or 1- or 2-vessel
CAC, independent of total Agatston score (2). It
stands to reason, therefore, that patients with high
CAC scores and multivessel CAC would be more
likely to undergo future coronary revascularization
and that those who undergo incident CABG
would be more likely to have baseline CAC
involving 3 or more coronary arteries (particularly
the left main), as compared with subjects who
underwent incident PCI. Although numerous
studies have convincingly and consistently
demonstrated the superior prognostic accuracy of
coronary calcium scoring vis-à-vis standard car-
diovascular risk variables and other novel risk
markers (e.g., high-sensitivity C-reactive protein)
for all-cause mortality and coronary heart disease
events (3,4), the relationship of total CAC score
and distribution with long-term incident coronary
revascularizations, and the type of revasculariza-
tion, was previously largely unknown.
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488The results of the current study provide us with
important data that further reﬁne the powerful
prognostic narrative of CAC testing. The authors
should be commended for this contribution.
There are, however, several caveats to the current
analysis that deserve discussion. Foremost, debate
endures as to the wisdom of including coronary
revascularization procedures as an outcome in
observational studies of cardiovascular prognosis,
due to the potential for this outcome to be
signiﬁcantly inﬂuenced by referral bias. Such re-
sidual bias could occur as a result of the inﬂuence
of the results of the index test (e.g., CAC score),
in which patients with higher degrees of CAC are
preferentially referred for additional ischemic
testing, which may invariably translate to higher
revascularization rates. Additionally, patient vari-
ables and provider and regional care variations in
coronary revascularization utilization may inﬂu-
ence referral patterns for invasive coronary angi-
ography, particularly in patients with stable clinical
presentations.
Concerns about the potential for induced pro-
cedural costs and resource utilization after CAC
screening were directly addressed by the EISNER
(Early Identiﬁcation of Subclinical Atherosclerosis
by Noninvasive Imaging Research) study, a pivotal
randomized, prospective trial that compared CAC
testing versus usual care in patients without base-
line cardiovascular disease for the primary outcome
of change in calculated cardiovascular risk (5).
Similar to the MESA study, the care of patients
during the 4 years of follow-up after CAC testing
was not dictated by investigators but was left
to patients and their providers. In an EISNER
cohort of 1,381 subjects, additional cardiovascular
testing was differentially performed according to
CAC severity, primarily in the small percentage of
subjects with advanced degrees of CAC. Specif-
ically, noninvasive testing for coronary artery dis-
ease was infrequent in patients with minimal or
no CAC (CAC <10) but was signiﬁcantly more
frequent among participants with CAC scores
$400. Similarly, the rate of invasive coronary
angiography and coronary revascularizations at 1
year were higher in those with severely elevated
CAC scores but was performed exclusively among
patients who had ﬁrst undergone noninvasive
testing and was ultimately overall performed in
only 19% of subjects with a CAC score $1,000.
Importantly, the addition of calcium scoring
did not signiﬁcantly increase overall estimatedhealthcare expenditures because the absence of
CAC was associated with signiﬁcantly lower rates
of subsequent cardiovascular testing and costs.
CAC scoring was ultimately associated with
overall signiﬁcant improvements in several car-
diovascular risk factors (blood pressure, low-
density lipoprotein cholesterol, and waist circum-
ference) (6).
Within the current study, because of its obser-
vational nature, the “appropriateness” of subsequent
coronary revascularizations could not be precisely
determined, and the inﬂuence of CAC test results
on subsequent patient and provider behavior
regarding cardiovascular testing and risk factor
modiﬁcation is regrettably unknown. Additionally,
the relationship of changes in post-test risk factors
to subsequent rates and type of coronary revascu-
larization cannot be elucidated. Furthermore, the
clinical outcomes and symptom status of patients
after revascularization were not reported. Fortu-
nately, the authors reassuringly demonstrate that
very few revascularizations occurred within 90 days
of CAC testing (median time to revascularization,
3.6 and 4.0 years for PCI and CABG, respectively)
and that the majority of revascularizations (85%)
were temporally related to MESA-adjudicated
angina or myocardial infarction. The authors also
performed a sensitivity analysis evaluating only
patients with symptoms/myocardial infarction and
reported no overall differences in the primary study
ﬁndings. While serial CAC scoring was performed
in many MESA study participants, with prior re-
ports highlighting the prognostic usefulness of
CAC progression on composite coronary outcomes
(that included symptom-related revascularization)
(7), the relationship of CAC progression to overall
long-term rates and type of coronary revasculari-
zation and post-revascularization outcomes is of
interest and remains unelucidated.
Notwithstanding these limitations, patients,
providers, and all imaging stakeholders will un-
doubtedly appreciate the additional pragmatic
prognostic information provided by this pivotal
MESA analysis. In fact, one would be remiss by
failing to mention the tremendously positive,
enduring impact that the MESA study, and
its cohort of tireless investigators, has had on the
ﬁeld of noninvasive atherosclerosis imaging and
cardiovascular risk prediction. We have learnedd
and continue to learndenormously from this
seminal National Institute of Health/National
Heart, Lung, and Blood Institute–sponsored study.
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489However, above all, data from MESA have made
the following statement nearly indisputable: CAC
testing is currently the most accurate noninvasive
method for the assessment of individual cardiovas-
cular risk in asymptomatic adults.Reprint requests and correspondence: Dr. Todd C.
Villines, Department of Medicine (Cardiology Service),
Walter Reed National Military Medical Center, Building
9A, Room 2335, 8901 Wisconsin Avenue, Bethesda,
Maryland 20889. E-mail: todd.c.villines.mil@mail.mil.R E F E R E N C E S1. Silverman MG, Harkness JR,
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